QTRX
Quanterix Corporation
NASDAQ · Healthcare · Medical - Devices · US
$2.69
+4.26%Year over year
Reported trailing growth
- Revenue
- +23.4%
- EBITDA
- -53.1%
- EBIT
- -46.9%
- EPS
- -44.5%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -3.4%
- EBITDA
- +52.5%
- EPS
- +40.3%
Three-year CAGR
- Revenue
- +9.5%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026